Lyell Immunopharma, Inc. · NASDAQ:LYEL
Innovative Cellular Therapeutics Holdings Ltd reported 1 trade in Lyell Immunopharma, Inc. shares (Form 4)
Traded Jun 29, 2026 · Filed Jul 1, 2026
On Jun 29, 2026, Innovative Cellular Therapeutics Holdings Ltd (10% owner) reported 1 trade in Lyell Immunopharma, Inc. shares, leaving 2,857,500 shares. Filed Jul 1, 2026 (Form 4).
- Shares
- 76,000 shares
- Holding after
- 2,857,500 shares
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | Other | 76,000 | 2,857,500 | Direct |
Source
Related
- Lyell Immunopharma, Inc.
- Innovative Cellular Therapeutics Holdings Ltd
- Lyell Immunopharma, Inc. shareholders
- Form 4 · Innovative Cellular Therapeutics Holdings Ltd · Jul 27, 2026
- Form 4 · Innovative Cellular Therapeutics Holdings Ltd · Jul 27, 2026
- Form 4 · Innovative Cellular Therapeutics Holdings Ltd · Jul 20, 2026
- Form 4 · Innovative Cellular Therapeutics Holdings Ltd · Jul 17, 2026
- Form 4 · Innovative Cellular Therapeutics Holdings Ltd · Jun 18, 2026
- Form 4 · Aguirre Jarrad Mattieu · Oct 13, 2026
- Form 4 · Shook David · Sep 10, 2026
- Form 4 · Seely Lynn · Aug 25, 2026
- Form 4 · Hill Stephen J. · Aug 25, 2026
- Form 4 · Lee Gary K. · Aug 25, 2026